Terumo Corporation (TYO:4543)

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013	Mar 31, 2012
Americas Revenue	443.41B	395.65B
Americas Revenue Growth	12.07%	20.63%
Europe Revenue	242.66B	218.29B
Europe Revenue Growth	11.16%	13.99%
China Revenue	91.31B	84.97B
China Revenue Growth	7.46%	7.00%
Asia and Others Revenue	131.90B	120.05B
Asia and Others Revenue Growth	9.87%	7.34%
Japan Revenue	222.60B	217.21B
Japan Revenue Growth	2.48%	2.88%

Revenue

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013	Mar 31, 2012
Cardiac and Vascular Company Revenue	676.42B	624.36B
Cardiac and Vascular Company Revenue Growth	8.34%	12.35%
Medical Care Solutions Company Revenue	216.14B	211.24B
Medical Care Solutions Company Revenue Growth	2.32%	6.92%
Blood and Cell Technologies Company Revenue	231.04B	200.28B
Blood and Cell Technologies Company Revenue Growth	15.36%	18.98%
Terumo Organ Technologies Revenue	7.99B	-
Adjustments from Revenue	294.00M	298.00M
Adjustments from Revenue Growth	-1.34%	20.16%

Adjusted EBIT

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013	Mar 31, 2012
Cardiac and Vascular Company Adjusted Operating Profit	163.99B	154.68B
Cardiac and Vascular Company Adjusted Operating Profit Growth	6.02%	24.89%
Medical Care Solutions Company Adjusted Operating Profit	21.57B	22.99B
Medical Care Solutions Company Adjusted Operating Profit Growth	-6.20%	16.19%
Blood and Cell Technologies Company Adjusted Operating Profit	33.64B	26.48B
Blood and Cell Technologies Company Adjusted Operating Profit Growth	27.01%	61.53%
Terumo Organ Technologies Adjusted Operating Profit	1.67B	-
Adjustments from Adjusted Operating Profit	-1.49B	-712.00M

Key Performance Indicators

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013	Mar 31, 2012
Cardiac and Vascular Company Production Result	620.90B
Cardiac and Vascular Company Production Result Growth	7.68%
Medical Care Solutions Company Production Result	197.08B
Medical Care Solutions Company Production Result Growth	2.17%
Blood and Cell Technologies Company Production Result	205.67B
Blood and Cell Technologies Company Production Result Growth	18.77%
Total Production Result	1.02T
Total Production Result Growth	8.59%

Updated Mar 31, 2026. Data Source: Fiscal.ai.